menu
    • menu

    Company profile for Mevion Medical Systems

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mevion Medical Systems exists to deliver on the promise of proton therapy for cancer centers, clinicians and patients worldwide. We invented compact proton therapy and are continuing to transform the industry and patient care with the MEVION S250 Series™. As a testament to the proven results delivered by our systems, we have more systems installed and treating patients than any other compact proton therapy manufacturer. The ...
    Mevion Medical Systems exists to deliver on the promise of proton therapy for cancer centers, clinicians and patients worldwide. We invented compact proton therapy and are continuing to transform the industry and patient care with the MEVION S250 Series™. As a testament to the proven results delivered by our systems, we have more systems installed and treating patients than any other compact proton therapy manufacturer. The MEVION S250 Series integrates our patented technology at the very forefront of proton therapy to deliver exceptional beam quality, industry-leading uptime, reduced system size and complexity, higher reliability.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mevion Medical SystemsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Foster St. Littleton, MA 01460
    Telephone
    Telephone
    +1 978 540 1500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mevion.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mevion-medical-systems
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/mevionmedical

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Carilion & Mevion Plan Proton Therapy Center in Virginia
    Carilion & Mevion Plan Proton Therapy Center in Virginia

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113737281/en/Carilion-Clinic-and-Mevion-Medical-Systems-Announce-Plans-to-Bring-Proton-Therapy-to-Southwest-Virginia

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Mevion Gets FDA Clearance for MEVION S250-FIT Proton Therapy
    Mevion Gets FDA Clearance for MEVION S250-FIT Proton Therapy

    15 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250915492581/en/Mevion-Medical-Systems-Announces-FDA-Clearance-for-MEVION-S250-FIT-Proton-Therapy-System

    BUSINESSWIRE
    15 Sep 2025
    Share Share
    MEVION S250i Boosts Proton Therapy Capacity in Mountain West
    MEVION S250i Boosts Proton Therapy Capacity in Mountain West

    22 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250822963875/en/Second-MEVION-S250i-to-Expand-Proton-Therapy-Capacity-in-the-Mountain-West

    BUSINESSWIRE
    22 Aug 2025
    Share Share
    BayCare Breaks Ground On Cancer Institute Expansion
    BayCare Breaks Ground On Cancer Institute Expansion

    19 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240919378048/en

    BUSINESSWIRE
    19 Sep 2024
    Share Share
    Mevion And NELCO Partner To Accelerate Proton Therapy Adoption
    Mevion And NELCO Partner To Accelerate Proton Therapy Adoption

    11 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240911896632/en

    BUSINESSWIRE
    11 Sep 2024
    Share Share
    Mevion Introduces New MEVION S250-FIT Proton Therapy System
    Mevion Introduces New MEVION S250-FIT Proton Therapy System

    21 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221021005026/en

    BUSINESSWIRE
    21 Oct 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search